NovoCure Limited (NASDAQ:NVCR – Get Rating) was the recipient of unusually large options trading on Tuesday. Stock traders purchased 5,873 call options on the company. This is an increase of 408% compared to the average volume of 1,157 call options. Institutional Investors Weigh In On NovoCure Institutional investors and hedge funds have recently added to […]